Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mehmet Sofuoglu & Thomas R Kosten. (2006) Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinion on Emerging Drugs 11:1, pages 91-98.
Read now
Read now
Vladimir Brusic, J Thomas August, MD & Nikolai Petrovsky. (2005) Information technologies for vaccine research. Expert Review of Vaccines 4:3, pages 407-417.
Read now
Read now
Tobin J Dickerson, Gunnar F Kaufmann & Kim D Janda. (2005) Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Expert Opinion on Biological Therapy 5:6, pages 773-781.
Read now
Read now
Articles from other publishers (39)
Jonaid Ahmad Malik & Javed N. Agrewala. (2023) Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction. International Immunopharmacology 119, pages 110210.
Crossref
Crossref
Susana Barbosa-Méndez, Maura Matus-Ortega, Ricardo Hernández Miramontes & Alberto Salazar-Juárez. (2021) The M3-TT Vaccine Decreases the Antinociceptive Effects of Morphine and Heroin in Mice. International Journal of Mental Health and Addiction 21:2, pages 783-802.
Crossref
Crossref
Fatima A. Hamid, Cheryl L. Marker, Michael D. Raleigh, Aaron Khaimraj, Scott Winston, Paul R. Pentel & Marco Pravetoni. (2022) Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine 40:23, pages 3244-3252.
Crossref
Crossref
Pooja Patnaik Kuppili, Harshini Manohar & Vikas Menon. (2018) Current status of vaccines in psychiatry—A narrative review. Asian Journal of Psychiatry 31, pages 112-120.
Crossref
Crossref
Suzette M. Evans, Richard W. Foltin, Martin J. Hicks, Jonathan B. Rosenberg, Bishnu P. De, Kim D. Janda, Stephen M. Kaminsky & Ronald G. Crystal. (2016) Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques. Pharmacology Biochemistry and Behavior 150-151, pages 76-86.
Crossref
Crossref
O. Ohia-Nwoko, T.A. Kosten & C.N. Haile. 2016. Animal Models for Medications Screening to Treat Addiction. Animal Models for Medications Screening to Treat Addiction
263
291
.
Coreen B. Domingo, Daryl Shorter & Thomas R. Kosten. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders
25
36
.
Jadwiga Zalewska-Kaszubska. (2015) Is immunotherapy an opportunity for effective treatment of drug addiction?. Vaccine 33:48, pages 6545-6551.
Crossref
Crossref
P. Garrido, A. Prat, I. Crespo, C. Lopez-Ortíz, D. Lumbreras, V. Bertran & J.J. Abades. (2013) Desarrollo de vacunas frente a sustancias adictivas (I). Vacunas anticocaína. Vacunas 14:2, pages 74-81.
Crossref
Crossref
P. Garrido, A. Prat, I. Crespo, A. Valverde & E. Salvador. (2012) Vacunas para la deshabituación tabáquica. Vacunas 13:4, pages 163-170.
Crossref
Crossref
Jamie Hartmann-Boyce, Kate Cahill, Dorothy Hatsukami & Jacques Cornuz. (2012) Nicotine vaccines for smoking cessation. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Sunmee Wee, Martin J Hicks, Bishnu P De, Jonathan B Rosenberg, Amira Y Moreno, Stephen M Kaminsky, Kim D Janda, Ronald G Crystal & George F Koob. (2011) Novel Cocaine Vaccine Linked to a Disrupted Adenovirus Gene Transfer Vector Blocks Cocaine Psychostimulant and Reinforcing Effects. Neuropsychopharmacology 37:5, pages 1083-1091.
Crossref
Crossref
X Y Shen, F M Orson & T R Kosten. (2011) Vaccines Against Drug Abuse. Clinical Pharmacology & Therapeutics 91:1, pages 60-70.
Crossref
Crossref
Fabien Rebeaud & Martin Bachmann. 2012. Innovation in Vaccinology. Innovation in Vaccinology
87
122
.
György BerencsiIIIIII & Katalin N. Szomor. 2012. Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis. Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis
281
333
.
Daryl Shorter & Thomas R Kosten. (2011) Novel pharmacotherapeutic treatments for cocaine addiction. BMC Medicine 9:1.
Crossref
Crossref
Gregory T. Collins, Matthew E. Zaks, Alyssa R. Cunningham, Carley St. Clair, Joseph Nichols, Diwahar Narasimhan, Mei-Chuan Ko, Roger K. Sunahara & James H. Woods. (2011) Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats. Drug and Alcohol Dependence 118:2-3, pages 158-165.
Crossref
Crossref
Maxine L. Stitzer, Tiffany Polk, Sarah Bowles & Thomas Kosten. (2010) Drug users’ adherence to a 6-month vaccination protocol: Effects of motivational incentives. Drug and Alcohol Dependence 107:1, pages 76-79.
Crossref
Crossref
Margaret Haney, Erik W. Gunderson, Huiping Jiang, Eric D. Collins & Richard W. Foltin. (2010) Cocaine-Specific Antibodies Blunt the Subjective Effects of Smoked Cocaine in Humans. Biological Psychiatry 67:1, pages 59-65.
Crossref
Crossref
Frank M. Orson, Berma M. Kinsey, Rana A.K. Singh, Yan Wu, Tracie Gardner & Thomas R. Kosten. (2008) Substance Abuse Vaccines. Annals of the New York Academy of Sciences 1141:1, pages 257-269.
Crossref
Crossref
Jacques Cornuz, Susanne Zwahlen, Walter Felix Jungi, Joseph Osterwalder, Karl Klingler, Guy van Melle, Yolande Bangala, Idris Guessous, Philipp Müller, Jörg Willers, Patrik Maurer, Martin F. Bachmann & Thomas Cerny. (2008) A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial. PLoS ONE 3:6, pages e2547.
Crossref
Crossref
Dorothy Hatsukami, Kate Cahill & Lindsay F Stead. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
H. Marie Lacy, Melinda G. Gunnell, Elizabeth M. Laurenzana & S. Michael Owens. (2008) Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody. International Immunopharmacology 8:1, pages 1-11.
Crossref
Crossref
Mark G. LeSage, Daniel E. Keyler & Paul R. Pentel. 2008. Drug Addiction. Drug Addiction
455
475
.
Tobin J. Dickerson & Kim D. Janda. 2008. Drug Addiction. Drug Addiction
217
229
.
Frank M. Orson, Berma M. Kinsey, Rana A. K. Singh, Yan Wu, Tracie Gardner & Thomas R. Kosten. (2007) The future of vaccines in the management of addictive disorders. Current Psychiatry Reports 9:5, pages 381-387.
Crossref
Crossref
Antonio Preti. (2007) REVIEW: New developments in the pharmacotherapy of cocaine abuse. Addiction Biology 12:2, pages 133-151.
Crossref
Crossref
Howard Hendrickson, Elizabeth Laurenzana & S. Michael Owens. (2006) Quantitative determination of total methamphetamine and active metabolites in rat tissue by liquid chromatography with tandem mass spectrometric detection. The AAPS Journal 8:4, pages E709-E717.
Crossref
Crossref
Paul Pentel, Mark LeSage, Daniel Keyler & Dorothy Hatsukami. 2006. Medication Treatments for Nicotine Dependence. Medication Treatments for Nicotine Dependence
151
166
.
Alexander G. Gabibov, Natalya A. Ponomarenko, Eugenia B. Tretyak, Mikhail A. Paltsev & Sergey V. Suchkov. (2006) Catalytic autoantibodies in clinical autoimmunity and modern medicine. Autoimmunity Reviews 5:5, pages 324-330.
Crossref
Crossref
Mark G. LeSage, Daniel E. Keyler & Paul R. Pentel. (2006) Current status of immunologic approaches to treating tobacco dependence: Vaccines and nicotine-specific antibodies. The AAPS Journal 8:1, pages E65-E75.
Crossref
Crossref
Mark G. LeSage, Daniel E. Keyler, Yoko Hieda, Greg Collins, Danielle Burroughs, Chap Le & Paul R. Pentel. (2005) Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats. Psychopharmacology 184:3-4, pages 409-416.
Crossref
Crossref
Christian Heidbreder. (2005) Novel pharmacotherapeutic targets for the management of drug addiction. European Journal of Pharmacology 526:1-3, pages 101-112.
Crossref
Crossref
Charles Dackis & Charles O'Brien. (2005) Neurobiology of addiction: treatment and public policy ramifications. Nature Neuroscience 8:11, pages 1431-1436.
Crossref
Crossref
Ilona A. Nekhayeva, Tatiana N. Nanovskaya, Paul R. Pentel, Dan E. Keyler, Gary D.V. Hankins & Mahmoud S. Ahmed. (2005) Effects of nicotine-specific antibodies, Nic311 and Nic-IgG, on the transfer of nicotine across the human placenta. Biochemical Pharmacology 70:11, pages 1664-1672.
Crossref
Crossref
Thomas Kosten & S. Michael Owens. (2005) Immunotherapy for the treatment of drug abuse. Pharmacology & Therapeutics 108:1, pages 76-85.
Crossref
Crossref
Tobin J. Dickerson & Kim D. Janda. (2005) RETRACTED ARTICLE: Recent advances for the treatment of cocaine abuse: Central nervous system immunopharmacotherapy. The AAPS Journal 7:3, pages E579-E586.
Crossref
Crossref
D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le & P. R. Pentel. (2005) MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS. Drug Metabolism and Disposition 33:7, pages 1056-1061.
Crossref
Crossref
Wynne K. Schiffer, Dianne E. Lee, Jonathan D. Brodie & Stephen L. Dewey. (2005) Imaging addiction with PET: is insight in sight?. Drug Discovery Today 10:8, pages 547-562.
Crossref
Crossref